S&P 500 Futures
(0.21%) 5 142.50 points
Dow Jones Futures
(0.21%) 38 521 points
Nasdaq Futures
(0.32%) 17 902 points
Oil
(-0.99%) $83.02
Gas
(1.72%) $1.956
Gold
(-0.26%) $2 341.00
Silver
(-0.16%) $27.49
Platinum
(0.39%) $925.70
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.09%) $11.02
USD/GBP
(-0.24%) $0.798
USD/RUB
(0.73%) $92.54

Realaus laiko atnaujinimai Bruker Corp [BRKR]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Devices
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 6.61%

BUY
63.27%
return 13.75%
SELL
44.00%
return -0.26%
Atnaujinta26 bal. 2024 @ 23:00

0.47% $ 80.97

PIRKIMAS 4991 min ago

@ $80.96

Išleistas: 25 bal. 2024 @ 22:38


Grąža: 0.01%


Ankstesnis signalas: bal. 25 - 19:49


Ankstesnis signalas: Pardavimas


Grąža: 0.63 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally...

Stats
Šios dienos apimtis 435 170
Vidutinė apimtis 831 755
Rinkos kapitalizacija 11.15B
EPS $0 ( 2024-02-13 )
Kita pelno data ( $0.460 ) 2024-05-02
Last Dividend $0.0500 ( 2024-02-29 )
Next Dividend $0 ( N/A )
P/E 27.92
ATR14 $1.870 (2.31%)
Insider Trading
Date Person Action Amount type
2023-12-16 Laukien Frank H Sell 1 404 Common Stock
2024-03-04 Requardt Hermann Fritz Buy 10 000 Common Stock
2024-03-04 Requardt Hermann Fritz Buy 5 000 Common Stock
2024-03-04 Requardt Hermann Fritz Sell 13 772 Common Stock
2024-03-04 Requardt Hermann Fritz Sell 1 228 Common Stock
INSIDER POWER
-31.65
Last 100 transactions
Buy: 483 678 | Sell: 1 126 200

Tūris Koreliacija

Ilgas: -0.77 (moderate negative)
Trumpas: -0.19 (neutral)
Signal:(30) Neutral

Bruker Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
SVFA0.921
SKYA0.916
AEAC0.915
PPTA0.914
ARRW0.913
AMTBB0.912
LFAC0.911
INTE0.911
ESCA0.91
HORI0.91
10 Labiausiai neigiamai susiję koreliacijos
BMRA-0.919
BWB-0.911
HRMY-0.91
SLN-0.906
INCR-0.903
SFST-0.903
EQBK-0.902
PEAR-0.902
PMVP-0.902
CSSEP-0.901

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bruker Corp Koreliacija - Valiuta/Žaliavos

The country flag -0.29
( neutral )
The country flag -0.39
( neutral )
The country flag 0.00
( neutral )
The country flag -0.61
( weak negative )
The country flag -0.23
( neutral )
The country flag 0.20
( neutral )

Bruker Corp Finansinės ataskaitos

Annual 2023
Pajamos: $2.96B
Bruto pelnas: $1.52B (51.17 %)
EPS: $2.92
FY 2023
Pajamos: $2.96B
Bruto pelnas: $1.52B (51.17 %)
EPS: $2.92
FY 2022
Pajamos: $2.53B
Bruto pelnas: $1.31B (51.59 %)
EPS: $2.00
FY 2022
Pajamos: $2.53B
Bruto pelnas: $1.31B (51.59 %)
EPS: $2.00

Financial Reports:

No articles found.

Bruker Corp Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0500
(N/A)
$0.0500
(N/A)
$0.0500
(N/A)
$0.0500
(N/A)
$0.0500
(N/A)
$0.0500
(N/A)
$0.0500
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Bruker Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.12 - Stable (22.41%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0400 2016-03-02
Last Dividend $0.0500 2024-02-29
Next Dividend $0 N/A
Payout Date 2024-03-15
Next Payout Date N/A
# dividends 33 --
Total Paid Out $1.410 --
Avg. Dividend % Per Year 0.21% --
Score 4.59 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.12
Div. Directional Score 8.92 --
Next Divdend (Est)
(2024-07-01)
$0.0512 Estimate 62.50 %
Dividend Stability
1.00 Excellent
Dividend Score
4.59
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2016 $0.160 0.68%
2017 $0.160 0.74%
2018 $0.160 0.46%
2019 $0.160 0.55%
2020 $0.160 0.31%
2021 $0.160 0.30%
2022 $0.200 0.25%
2023 $0.200 0.29%
2024 $0.0500 0.07%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1441.5007.1210.00[0 - 0.5]
returnOnAssetsTTM0.1011.2006.657.98[0 - 0.3]
returnOnEquityTTM0.3381.5007.3510.00[0.1 - 1]
payoutRatioTTM0.0688-1.0009.31-9.31[0 - 1]
currentRatioTTM1.8000.8006.004.80[1 - 3]
quickRatioTTM0.9330.8009.227.37[0.8 - 2.5]
cashRatioTTM0.4061.5008.8510.00[0.2 - 2]
debtRatioTTM0.303-1.5004.94-7.42[0 - 0.6]
interestCoverageTTM-11.981.000-5.55-5.55[3 - 30]
operatingCashFlowPerShareTTM2.412.009.2010.00[0 - 30]
freeCashFlowPerShareTTM1.6712.009.1610.00[0 - 20]
debtEquityRatioTTM0.936-1.5006.26-9.38[0 - 2.5]
grossProfitMarginTTM0.5101.0004.844.84[0.2 - 0.8]
operatingProfitMarginTTM0.1491.0009.029.02[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2721.0009.609.60[0.2 - 2]
assetTurnoverTTM0.6980.8008.686.95[0.5 - 2]
Total Score11.71

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM27.581.0007.320[1 - 100]
returnOnEquityTTM0.3382.508.3010.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.6712.009.4410.00[0 - 30]
dividendYielPercentageTTM0.2471.5003.820[0 - 0.4]
operatingCashFlowPerShareTTM2.412.009.2010.00[0 - 30]
payoutRatioTTM0.06881.5009.31-9.31[0 - 1]
pegRatioTTM0.3611.500-0.9290[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1181.0009.550[0.1 - 0.5]
Total Score6.12

Bruker Corp

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.